H. Yagita

Immunology · 2001–2015

A researcher in the Science corpus: 15 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 179 citations into it; #819 of 2,160 by trust here, #183 by citations

Whom H. Yagita trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Smyth (in Immunology)

Who trusts H. Yagita

1. G. Freeman (in Immunology)
2. A. Ashkenazi (in Immunology)
3. M. Smyth (in Immunology)
4. James P. Allison (in Immunology)
5. Lieping Chen (in Immunology)

Papers from H. Yagita's perspective

Ordered by how strongly the researchers H. Yagita trusts endorse each paper. Same corpus, a different order for every researcher.

1. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (Science)
2. Modulation of tryptophan catabolism by regulatory T cells (Nature Immunology)
3. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
4. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (Journal of Clinical Investigation)
5. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. (Immunity)
6. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants (Science)
7. Biology of Natural Killer Cells (Advances in Immunology)
8. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
9. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells (Nature Immunology)
10. Foxp3 instability leads to the generation of pathogenic memory T cells in vivo (Nature Immunology)

Their papers

• Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells (2001) — 796 citations
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1 (2002) — 671 citations
• VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors (2015) — 1,071 citations
• Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma (2013) — 1,396 citations
• Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 (2012) — 783 citations
• PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors (2010) — 1,844 citations
• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts (2010) — 881 citations
• ATP drives lamina propria TH17 cell differentiation (2008) — 1,096 citations
• Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. (2007) — 804 citations
• Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer (2007) — 869 citations
• Activation of NK cell cytotoxicity. (2005) — 718 citations
• Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer (2005) — 770 citations
• The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice (2003) — 839 citations
• Expression of Programmed Death 1 Ligands by Murine T Cells and APC1 (2002) — 825 citations
• New aspects of natural-killer-cell surveillance and therapy of cancer (2002) — 782 citations